Lista de

cyclin D1
36
"Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation" (2018) Maymó, J.L.;Riedel, R.;Pérez-Pérez, A. (...)Varone, C.L. PLoS ONE. 13(1)
"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811
"The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells" (2016) Chaves-Ferreira, M.;Krenn, G.;Vasseur, F. (...)Laderach, D. Biology Direct. 11(1)
"The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells" (2016) Chaves-Ferreira, M.;Krenn, G.;Vasseur, F. (...)Laderach, D. Biology Direct. 11(1)
"The RNA Response to DNA Damage" (2016) Giono, L.E.;Nieto Moreno, N.;Cambindo Botto, A.E. (...)Kornblihtt, A.R. Journal of Molecular Biology. 428(12):2636-2651
"Association of HO-1 and BRCA1 is critical for the maintenance of cellular homeostasis in prostate cancer" (2015) Labanca, E.;De Luca, P.;Gueron, G. (...)De Siervi, A. Molecular Cancer Research. 13(11):1455-1464
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Hsp90-binding immunophilins as a potential new platform for drug treatment" (2013) Erlejman, A.G.; Lagadari, M.; Galigniana, M.D. Future Medicinal Chemistry. 5(5):591-607
"BRCA1 and p53 regulate critical prostate cancer pathways" (2013) De Luca, P.;Moiola, C.P.;Zalazar, F. (...)De Siervi, A. Prostate Cancer and Prostatic Diseases. 16(3):233-238
"Unveiling the association of STAT3 and HO-1 in prostate cancer: Role beyond heme degradation" (2012) Elguero, B.;Gueron, G.;Giudice, J. (...)Vazquez, E. Neoplasia (United States). 14(11):1043-1056
"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320
"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636
"H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1" (2011) Ibañez, I.L.;Policastro, L.L.;Tropper, I. (...)Durán, H. Cancer Letters. 305(1):58-68
"H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1" (2011) Ibañez, I.L.;Policastro, L.L.;Tropper, I. (...)Durán, H. Cancer Letters. 305(1):58-68
"H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1" (2011) Ibañez, I.L.;Policastro, L.L.;Tropper, I. (...)Durán, H. Cancer Letters. 305(1):58-68
"H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1" (2011) Ibañez, I.L.;Policastro, L.L.;Tropper, I. (...)Durán, H. Cancer Letters. 305(1):58-68
"Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels" (2010) Ahtiainen, P.;Sharp, V.;Rulli, S.B. (...)Huhtaniemi, I. Endocrine-Related Cancer. 17(3):611-621
"Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells" (2010) Schaaf, C.;Shan, B.;Onofri, C. (...)Renner, U. Neuroendocrinology. 91(2):200-210
"Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo" (2009) Schaaf, C.;Shan, B.;Buchfelder, M. (...)Renner, U. Endocrine-Related Cancer. 16(4):1339-1350
"Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo" (2009) Schaaf, C.;Shan, B.;Buchfelder, M. (...)Renner, U. Endocrine-Related Cancer. 16(4):1339-1350
"Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric-oxide synthase" (2006) Franco, M.C.;Antico Arciuch, V.G.;Peralta, J.G. (...)Carreras, M.C. Journal of Biological Chemistry. 281(8):4779-4786
"Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric-oxide synthase" (2006) Franco, M.C.;Antico Arciuch, V.G.;Peralta, J.G. (...)Carreras, M.C. Journal of Biological Chemistry. 281(8):4779-4786
"Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric-oxide synthase" (2006) Franco, M.C.;Antico Arciuch, V.G.;Peralta, J.G. (...)Carreras, M.C. Journal of Biological Chemistry. 281(8):4779-4786
"Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation" (2006) Dekanty, A.;Sauane, M.;Cadenas, B. (...)Jiménez De Asúa, L. Journal of Biological Chemistry. 281(10):6136-6143
"Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation" (2006) Dekanty, A.;Sauane, M.;Cadenas, B. (...)Jiménez De Asúa, L. Journal of Biological Chemistry. 281(10):6136-6143
"Differential involvement of ERK1-2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2α" (2006) Dekanty, A.;Giulianelli, S.;Coso, O.A. (...)Jimenez de Asua, L. FEBS Letters. 580(10):2512-2516
"Differential involvement of ERK1-2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2α" (2006) Dekanty, A.;Giulianelli, S.;Coso, O.A. (...)Jimenez de Asua, L. FEBS Letters. 580(10):2512-2516
"Differential involvement of ERK1-2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2α" (2006) Dekanty, A.;Giulianelli, S.;Coso, O.A. (...)Jimenez de Asua, L. FEBS Letters. 580(10):2512-2516
"Differential involvement of ERK1-2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2α" (2006) Dekanty, A.;Giulianelli, S.;Coso, O.A. (...)Jimenez de Asua, L. FEBS Letters. 580(10):2512-2516
"Mechanisms of cell cycle arrest in response to TGF-β in progestin- dependent and -independent growth of mammary tumors" (2001) Salatino, M.;Labriola, L.;Schillaci, R. (...)Elizalde, P.V. Experimental Cell Research. 265(1):152-166